Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
äŒæ¥ã³ãŒãPYPD
äŒç€ŸåPolyPid Ltd
äžå Žæ¥Jun 26, 2020
æé«çµå¶è²¬ä»»è
ãCEOãAkselbrad (Dikla Czaczkes)
åŸæ¥å¡æ°57
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 26
æ¬ç€Ÿæåšå°18 Hasivim Street, P.O Box 7126
éœåžPETAH TIKVA
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·4917002
é»è©±çªå·972747195700
ãŠã§ããµã€ãhttps://www.polypid.com
äŒæ¥ã³ãŒãPYPD
äžå Žæ¥Jun 26, 2020
æé«çµå¶è²¬ä»»è
ãCEOãAkselbrad (Dikla Czaczkes)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã